BioCentury
ARTICLE | Finance

Making introductions

How Newton hopes to facilitate deals between Europe, Japan with €200 million fund

November 10, 2017 11:38 PM UTC

Newcomer Newton Biocapital is raising a €200 million ($231.7 million) fund to invest in early stage healthcare companies in Europe and Japan and facilitate partnerships and M&A between the two regions.

Newton, which was established in April, has offices in Brussels and Tokyo and is led by established life sciences investors Alain Parthoens and Goro Takeda. ...